Developing Subcutaneous Formulations for Irisin as a Potential Therapeutic

Authors

Hao Lou (ORCID: https://orcid.org/0000-0003-0218-6382)
Michael J. Hageman (ORCID: https://orcid.org/0000-0003-0824-6577)
Xi Luan
Gang Hu (ORCID: https://orcid.org/0000-0001-9204-9140)

Institutions

University of Kansas (US)

Publication Details

Journal: Pharmaceutical Research
Published: 2025-10-22
DOI: https://doi.org/10.1007/s11095-025-03945-w
Primary Topic: Adipose Tissue and Metabolism
Type: article
Field-Weighted Citation Impact: 0.00

Funders

National Institutes of Health
National Center for Advancing Translational Sciences

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Developing Subcutaneous Formulations for Irisin as a Potential Therapeutic

Hao Lou, Michael J. Hageman, Xi Luan, Gang Hu

Oct 22, 2025

Pharmaceutical Research

Adipose Tissue and Metabolism

article

Developing Subcutaneous Formulations for Irisin as a Potential Therapeutic

Hao Lou, Michael J. Hageman, Xi Luan, Gang Hu

October 22, 2025article en

Abstract

No abstract available for this paper.

Pharmaceutical ResearchVol. 42(12)

University of Kansas (US)

National Institutes of Health, National Center for Advancing Translational Sciences

Openalex Percentile: Top 62%

Adipose Tissue and Metabolism

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Developing Subcutaneous Formulations for Irisin as a Potential Therapeutic — Hao Lou, Michael J. Hageman, et al. · Pharmaceutical Research (2025) | TGRS Research Map | TGRS